Kinetics refers to the study of reaction rates and the factors influencing how quickly chemical or biochemical processes occur, including enzyme-catalysed reactions, drug metabolism, receptor binding, and degradation pathways. In biopharmaceutical contexts, kinetics may describe drug-target binding behaviour, metabolic clearance rates, or the time-dependent progression of biological responses. Kinetic analysis supports mechanistic understanding by linking molecular interactions to observable outcomes across time.
The biopharmaceutical industry relies on kinetic principles across discovery, development, and manufacturing. Drug-target binding kinetics influence efficacy and duration of action, with residence time emerging as an important parameter beyond simple affinity. Metabolic kinetics guide optimisation of stability and clearance, informing dosing strategies and exposure predictions. Manufacturing process kinetics describe reaction progress in biocatalysis, degradation in formulation, and process stability across production steps. Regulatory submissions often include kinetic stability and degradation information supporting shelf-life claims and storage conditions. As quantitative pharmacology advances, kinetics continues providing essential frameworks connecting molecular behaviour to clinical performance and product quality.
Analytical Development & Characterisation
Kinetics
Kinetics is the study of the rates and mechanisms of biological, chemical or physical processes and how they change over time.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →